$ cat molecule-index.md
# Molecule Index
> Same ingredient. Different brand. Different country. Different price.
Source-backed medicine price notes for the drugs we can verify now; ingredient-first index for the rest.
Anatherum Muricatu o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Herplex
Anatherum Muricatum, Clematis Erecta, Mezereum, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox, Thuja Occidentalis, · Oral
Asclepias Tuberosa o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Virex , Thuja Occidentalis, Calcarea Arsenicica, Camphora, Influenzinum, Cytomegalovirus N
Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinali · Oral
Sabal Serrulata, T o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Prostate Liquescence Liquid
Sabal Serrulata, Taraxacum Officinale, Phytolacca Decandra, Thuja Occidentalis, Estradiol, Progesterone, Conium Maculatu · Oral
Echinacea (Angusti o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Lymph Liquescence , Phytolacca Decandra, Thuja Occidentalis, Arsenicum Iodatum, Curcuma Lo
Echinacea (Angustifolia · Oral
Carbo Vegetabilis, o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Mole Remover Liquid
Carbo Vegetabilis, Graphites, Lycopodium Clavatum, Phytolacca Decandra, Thuja Occidentalis · Oral
Calendula Officina o--o \/ /\ o--o
:| molecule · DailyMed SPL index
H-Moles Formula Oil
Calendula Officinalis, Phytolacca Decandra, Thuja Occidentalis · Oral
Phytolacca Decandr o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Sp1 Formula Oil
Phytolacca Decandra, Thuja Occidentalis · Oral
Phytolacca Decandr o--o \/ /\ o--o
:| molecule · DailyMed SPL index
H-Warts Formula Oil
Phytolacca Decandra, Thuja Occidentalis · Oral
$ cat method.md
Ingredient first, prices second
Now
Index 100,000 drug/package records by active ingredient, brand, route, class hint, source, and risk/price-gap watch signals.
Next
Attach daily country snapshots for US, Canada, UK, India, Mexico, and EU comparator markets.
Later
Track pharmacy-level prices, coupons, cash-pay providers, generic availability, and verified substitution boundaries.